Miglena Marinova Achkar | Medicine | Innovative Research Award

Innovative Research Award

Researcher Information
Affiliation Medical University Varna
Country Bulgaria
Scopus ID 57739433300
Documents 3
Citations 33
h-index 2
Subject Area Medicine
Event Scientific World Research Awards

Miglena Marinova Achkar

Medical University Varna, Bulgaria

Miglena Marinova Achkar is affiliated with Medical University Varna, Bulgaria, and has contributed to medical research focusing on pediatric allergy, environmental determinants of disease, and preventive healthcare. Her scholarly publications demonstrate an evidence-based approach to clinical medicine and public health, making her profile relevant for recognition through the Scientific World Research Awards.[1]

Abstract

This article summarizes the academic profile of Miglena Marinova Achkar, highlighting scholarly activities in medicine, pediatric allergy, and environmental health research. Available publication metrics and research outputs indicate contributions supporting evidence-based healthcare and preventive medicine while demonstrating suitability for academic recognition.[1]

Keywords

Medicine, Pediatrics, Allergy, Environmental Health, Atopy, Child Health, Epidemiology, Preventive Medicine, Clinical Research, Bulgaria

Introduction

Miglena Marinova Achkar’s research focuses on pediatric medicine and allergic diseases, emphasizing environmental influences on childhood health. Her published studies contribute valuable clinical observations supporting preventive healthcare strategies and encourage evidence-based decision-making for physicians, researchers, and healthcare policymakers.[1]

Research Profile

Her Scopus profile includes peer-reviewed publications addressing pediatric allergy and environmental determinants affecting children’s health. With measurable citations and an established h-index, her academic record reflects participation in internationally indexed research contributing to contemporary medical knowledge.[1]

Research Contributions

Her investigations examine relationships between environmental exposures and allergic conditions among children with hereditary susceptibility. These findings provide clinically relevant evidence supporting early prevention, risk assessment, and improved understanding of pediatric allergic disease development within healthcare practice.[1]

Publications

Published research includes studies investigating environmental determinants of allergic diseases in children, emphasizing epidemiological evaluation and clinical interpretation. These peer-reviewed publications contribute reliable scientific evidence supporting pediatric medicine, allergy prevention, and public health research initiatives.[1]

Research Impact

Citation metrics indicate that her work has attracted scholarly attention within pediatric and allergy research communities. The research supports ongoing investigations into childhood allergic diseases and contributes useful evidence for improving preventive healthcare and clinical management practices.[1]

Award Suitability

Her documented research achievements, peer-reviewed publications, citation record, and commitment to pediatric medical science demonstrate qualities aligned with the objectives of the Scientific World Research Awards. The profile reflects meaningful academic contributions deserving consideration for research recognition.[1]

Conclusion

Miglena Marinova Achkar has established an emerging academic profile through research addressing pediatric allergy and environmental health. Her publications, citations, and evidence-based investigations contribute to medical science while supporting continued scholarly development and international academic recognition.[1]

 

References

  1. Early-Life Environmental Determinants of Allergic Conditions in Children with Atopic Heredity: A Single Center Cross-Sectional Study from Bulgaria.
    https://www.mdpi.com/2076-3271/13/3/198
  2. Elsevier. (n.d.). Scopus author details: Miglena Marinova Achkar, Author ID 57739433300. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57739433300
  3. Scientific World Research Awards. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Anuradha Kunthur | Medicine | Innovative Research Award

Innovative Research Award

Anuradha Kunthur
University of Arkansas

Anuradha Kunthur
Affiliation University of Arkansas
Country United States
Scopus ID 12805295200
Documents 7
Citations 154
h-index 5
Subject Area Medicine
Event Scientific World Research Awards

The Innovative Research Award recognizes scholarly achievement, research originality, and meaningful contributions to scientific advancement. This academic recognition article highlights the research profile, publication record, and scholarly influence of Anuradha Kunthur, affiliated with the University of Arkansas. The assessment considers research productivity, citation performance, subject expertise, and potential contributions to the advancement of medical sciences. The profile reflects academic indicators commonly used in research evaluation and award selection processes.[1]

Abstract

This article presents an academic overview of Anuradha Kunthur and evaluates the researcher’s suitability for the Innovative Research Award. Affiliated with the University of Arkansas, the researcher has contributed to the field of medicine through scholarly publications, interdisciplinary inquiry, and evidence-based investigations. Academic performance indicators, including publication output, citation activity, and h-index values, demonstrate measurable engagement with the scientific community. The profile highlights research accomplishments, publication quality, scholarly influence, and broader relevance to contemporary medical challenges. These characteristics collectively support recognition within competitive international research award programs and academic excellence initiatives.[1][2]

Keywords

Innovative Research Award, Medical Research, Scholarly Impact, Citation Analysis, Research Excellence, University of Arkansas, Scientific Achievement, Academic Recognition.

Introduction

Academic awards play an important role in recognizing research excellence, innovation, and scientific contributions. The Innovative Research Award acknowledges researchers whose scholarly activities demonstrate originality, methodological rigor, and relevance to advancing knowledge. Evaluation often includes publication quality, citation influence, and contributions to addressing real-world challenges through scientific investigation.[2]

Research Profile

Anuradha Kunthur is affiliated with the University of Arkansas and has established a research profile within the medical sciences. The available scholarly metrics indicate a focused publication record supported by consistent citation activity. Research visibility reflected through indexed publications and citation performance demonstrates engagement with international academic audiences and contribution to evidence-based scientific discourse.[1]

Research Contributions

The researcher’s contributions are associated with advancing understanding in medicine through analytical investigation and scholarly publication. Research activities support the development of scientific knowledge, encourage interdisciplinary collaboration, and provide insights relevant to healthcare improvement. Citation performance suggests that published findings have contributed to ongoing academic discussions and informed subsequent studies within related fields.[1][3]

Publications

The publication portfolio consists of peer-reviewed scholarly works indexed within recognized academic databases. These publications contribute to the dissemination of research findings and support broader scientific communication. The documented publication count, combined with citation activity, reflects sustained participation in scholarly publishing and knowledge exchange within the medical research community.[1]

Research Impact

Research impact can be assessed through citation metrics, scholarly visibility, and influence on future investigations. With 154 citations and an h-index of 5, the researcher demonstrates measurable academic engagement. These indicators suggest that published work has attracted attention from peers and contributed to the broader scientific literature in meaningful ways.[1][4]

Award Suitability

The Innovative Research Award emphasizes originality, scientific contribution, and measurable research influence. Based on available academic indicators, Anuradha Kunthur demonstrates characteristics aligned with award evaluation criteria. Publication output, citation performance, institutional affiliation, and documented scholarly activity collectively support consideration for recognition within international research award programs dedicated to scientific excellence and innovation.[1][2]

Conclusion

Anuradha Kunthur’s academic profile reflects meaningful participation in medical research through scholarly publication and citation impact. The combination of research productivity, scientific engagement, and measurable scholarly influence supports recognition within the framework of the Innovative Research Award. Continued research activity and knowledge dissemination are expected to contribute positively to the advancement of medical science and academic scholarship.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anuradha Kunthur, Author ID 12805295200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12805295200
  2. Scientific World Research Awards. (n.d.). Innovative Research Award evaluation and recognition framework.
    https://scientificworld.net/
  3. Marisa Navoa ∙ Anuradha Kunthurb ∙ Martina L. Badell. (2006). Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.
    https://doi.org/10.1016/j.ygyno.2006.04.002
  4. Anuradha Kunthur. (2019). A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy.
    https://doi.org/10.1177/1078155219890653

Sihe Zhang | Medicine | Distinguished Scientist Award

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Jacek Kotuła | Medicine | Research Excellence Award

Assist. Prof. Dr. Jacek Kotuła | Medicine | Research Excellence Award

Doctor | University of Wrocław | Poland

Assist. Prof. Dr. Jacek Kotuła, affiliated with Wrocław Medical University, is a researcher in orthodontics, dentistry, and medical ethics. His research interests include cephalometric analysis, bone remodeling, and orthodontic biomechanics. He has strong skills in CBCT imaging, finite element modeling, and clinical research. With impactful publications in medical journals, he has gained academic recognition. According to Google Scholar, he has 230 citations, an h-index of 9, and an i10-index of 8, reflecting his contributions to modern orthodontic science.

 

Citation Metrics (Google Scholar)

230
150
100
50
0

Citations

230

i10-index

8

h-index

9

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications

 

Dulce Calvo | Medicine | Research Excellence Award

Mrs. Dulce Calvo | Medicine | Research Excellence Award

PhD Student | Autonomous University of Barcelona | Spain

Citation Metrics (Scopus)

9
7
5
3
0

Citations

9

Documents

3

h-index

1

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Shahin Zandieh | Medicine | Innovative Research Award

Prof. Dr. Shahin Zandieh | Medicine | Innovative Research Award

Professor | Hanusch-Krankenhaus | Austria

Prof. Dr. Shahin Zandieh is a medical imaging and diagnostic radiology specialist whose research spans musculoskeletal biomechanics, cardiovascular imaging, oncologic radiology, and advanced radiomics. With 49 publications, over 550 citations, and an h-index of 12, his scientific work reflects a strong interdisciplinary approach to clinical diagnosis, disease characterization, and imaging-guided evaluation of structural abnormalities. His contributions extend across orthopedic, cardiovascular, endocrine, and oncological systems through innovative use of MRI, CT, X-ray, and radiomic feature extraction.A notable component of Prof. Dr. Zandieh’s research focuses on orthopedic imaging and biomechanical assessment, including comparative studies such as the analysis of proximal chevron osteotomy versus Lapidus arthrodesis in managing hallux valgus deformities. His work provides clinically meaningful insights for surgeons, improving treatment selection, operative planning, and postoperative evaluation.In the field of cardiovascular imaging, he has explored rare cardiac pathologies such as “toothpaste tumor” manifestations of the mitral valve, enhancing the diagnostic awareness of uncommon presentations through multimodal radiologic evaluation. His studies also extend to endocrine-related morphologic changes, such as MRI-based radiomics used to detect cardiac variations influenced by autoimmune thyroid disorders—paving the way for AI-assisted diagnostic tools.Prof. Dr. Zandieh has also contributed to oncologic radiology, documenting rare metastatic patterns including giant ovarian metastasis from breast cancer. These case-based investigations broaden clinician understanding of atypical disease progression.Collectively, his research strengthens clinical imaging practice by integrating radiomics, rare-case documentation, biomechanics, and cross-system diagnostic strategies—advancing precision diagnosis, personalized treatment planning, and the broader field of radiological science.

Profiles: Scopus |ResearchGate

Featured Publications

Fezoulidis, N., Slavicek, J., Nonninger, J.-N., … , & Zandieh, S. (2025). Quantitative CT perfusion and radiomics reveal complementary markers of treatment response in HCC patients undergoing TACE.

Behanova, M., Sokhan, A., Haschka, J., … , & Kocijan, R. (2025). AI-supported opportunistic detection of vertebral fractures on routine CT scans: Diagnostic performance and clinical relevance.

Al-Taiee, B., Lamiss, M., Slavicek, J., … , & Zandieh, S. (2025). Disseminated miliary tuberculosis following intravesical BCG therapy: A rare but serious complication.

Kainz, B., Hergan, K., & Zandieh, S. (2025). Große Ovarialmetastase beim Mammakarzinom: Ein seltener Fall.

Prof. Dr. Shahin Zandieh’s work advances medical imaging by integrating radiomics, AI-supported diagnostics, and multimodal radiology to improve early disease detection, treatment response evaluation, and clinical decision-making. His contributions enhance patient safety, elevate diagnostic precision across oncology, cardiology, musculoskeletal, and infectious diseases, and support global healthcare innovation by translating advanced imaging technologies into practical, life-saving clinical applications.